Literature DB >> 23707383

The effects of cognitive behavioral therapy for postcancer fatigue on perceived cognitive disabilities and neuropsychological test performance.

Martine M Goedendorp1, Hans Knoop2, Marieke F M Gielissen3, Constans A H H V M Verhagen4, Gijs Bleijenberg2.   

Abstract

CONTEXT: After successful cancer treatment, a substantial number of survivors continue to experience fatigue and related concentration and memory problems. Severe fatigue after cancer treatment can be treated effectively with cognitive behavioral therapy (CBT), but it is unclear whether CBT has an effect on cognitive functioning.
OBJECTIVES: We hypothesized that patients would report less cognitive disability after treatment with CBT for cancer-related fatigue. CBT was not expected to affect neuropsychological test performance, as it has been shown that fatigue is not associated with test performance.
METHODS: Data were used from a randomized controlled trial in which 98 severely fatigued cancer survivors, treated at least one year previously, were assessed at baseline (T1) and six months post-baseline (T2). Patients were randomly assigned to receive CBT (n = 50) or to a waiting list (WL) control condition (n = 48). Self-reported cognitive disability was assessed by the Concentration subscale of the Checklist Individual Strength and the Alertness Behavior subscale of the Sickness Impact Profile. Neuropsychological test performance was measured by the symbol digit modalities task and two reaction time tasks.
RESULTS: Patients who received CBT for post-cancer fatigue reported significantly less cognitive disability compared with those in the WL group. CBT also was associated with a clinically relevant reduction in concentration problems (CBT, 32% vs. WL, 2%). There were no significant differences in neuropsychological test performance between the CBT and WL groups.
CONCLUSION: CBT for post-cancer fatigue has already been shown to be an effective therapy. The present study demonstrates that CBT also may lead to a decrease in perceived cognitive disability.
Copyright © 2014 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; cognitive behavioral therapy; cognitive disabilities; concentration; fatigue; neuropsychological functioning

Mesh:

Year:  2013        PMID: 23707383     DOI: 10.1016/j.jpainsymman.2013.02.014

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  14 in total

1.  Impact of transcranial direct current stimulation on sustained attention in breast cancer survivors: Evidence for feasibility, tolerability, and initial efficacy.

Authors:  Alexandra M Gaynor; Denise Pergolizzi; Yesne Alici; Elizabeth Ryan; Katrazyna McNeal; Tim A Ahles; James C Root
Journal:  Brain Stimul       Date:  2020-04-27       Impact factor: 8.955

2.  Cancer-related fatigue: results from patient experience surveys undertaken in a UK regional cancer centre.

Authors:  Sarah James; Pamela Wright; Clare Scarlett; Teresa Young; Humaira Jamal; Ranjena Verma
Journal:  Support Care Cancer       Date:  2014-12-23       Impact factor: 3.603

Review 3.  Neuropsychological Interventions for Cancer-Related Cognitive Impairment: A Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Andy S K Cheng; Xiaoming Wang; Niu Niu; Minyu Liang; Yingchun Zeng
Journal:  Neuropsychol Rev       Date:  2022-01-29       Impact factor: 7.444

4.  Change in Patients' Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma.

Authors:  Anna Barata; Aasha I Hoogland; Anuhya Kommalapati; Jennifer Logue; Taylor Welniak; Kelly A Hyland; Sarah L Eisel; Brent J Small; Reena V Jayani; Margaret Booth-Jones; Laura B Oswald; Brian D Gonzalez; Kedar S Kirtane; Michael D Jain; Sepideh Mokhtari; Julio C Chavez; Aleksandr Lazaryan; Bijal D Shah; Frederick L Locke; Heather S L Jim
Journal:  Transplant Cell Ther       Date:  2022-05-14

Review 5.  Early palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers.

Authors:  Anthony Byrne; Anna Torrens-Burton; Stephanie Sivell; Fabio Ynoe Moraes; Helen Bulbeck; Mark Bernstein; Annmarie Nelson; Helen Fielding
Journal:  Cochrane Database Syst Rev       Date:  2022-01-06

6.  Survivorship: cognitive function, version 1.2014.

Authors:  Crystal S Denlinger; Jennifer A Ligibel; Madhuri Are; K Scott Baker; Wendy Demark-Wahnefried; Debra L Friedman; Mindy Goldman; Lee Jones; Allison King; Grace H Ku; Elizabeth Kvale; Terry S Langbaum; Kristin Leonardi-Warren; Mary S McCabe; Michelle Melisko; Jose G Montoya; Kathi Mooney; Mary Ann Morgan; Javid J Moslehi; Tracey O'Connor; Linda Overholser; Electra D Paskett; Muhammad Raza; Karen L Syrjala; Susan G Urba; Mark T Wakabayashi; Phyllis Zee; Nicole R McMillian; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2014-07       Impact factor: 11.908

Review 7.  Cognitive Rehabilitation for Cognitive Dysfunction after Cancer and Cancer Treatment: Implications for Nursing Practice.

Authors:  Diane Von Ah; Adele Crouch
Journal:  Semin Oncol Nurs       Date:  2020-01-17       Impact factor: 2.315

Review 8.  Meta-Analysis of the Effects of Neuropsychological Interventions on Cognitive Function in Non-Central Nervous System Cancer Survivors.

Authors:  Yingchun Zeng; Andy S K Cheng; Chetwyn C H Chan
Journal:  Integr Cancer Ther       Date:  2016-05-04       Impact factor: 3.279

Review 9.  Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.

Authors:  Charlene J Treanor; Una C McMenamin; Roisin F O'Neill; Chris R Cardwell; Mike J Clarke; Marie Cantwell; Michael Donnelly
Journal:  Cochrane Database Syst Rev       Date:  2016-08-16

Review 10.  Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.

Authors:  Rebecca A Harrison; Noha Sharafeldin; Jennie L Rexer; Brennan Streck; Melissa Petersen; Ashley M Henneghan; Shelli R Kesler
Journal:  Oncologist       Date:  2021-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.